New combo shows promise for untreated mantle cell lymphoma
NCT ID NCT02682641
First seen Apr 01, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study tests a combination of two drugs, ibrutinib and rituximab, in 50 adults with a slow-growing form of mantle cell lymphoma who have not had prior treatment. The main goal is to see how many patients achieve complete remission one year after starting treatment. Researchers will also study the genetic profile of the tumors to better understand the disease and response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
-
Hospital Clínico de Valencia
Valencia, Valencia, Spain
-
Hospital Costa del Sol
Marbella, Málaga, Spain
-
Hospital General Universitario Santa Lucía
Cartagena, Murcia, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Madrid, 28041, Spain
-
Hospital Universitario Clinico de Salamanca
Salamanca, Spain
-
Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, Spain
-
Hospital Universitario Mútua Terrassa
Terrassa, Barcelona, Spain
-
Hospital Universitario Ramon y Cajal
Madrid, Madrid, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, Barcelona, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Sevilla, Spain
-
Hospital Universitario de Burgos
Burgos, Burgos, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain
-
Institut Català d'Oncologia
Barcelona, Barcelona, Spain
-
MD Anderson Cancer Center
Madrid, Madrid, Spain
Conditions
Explore the condition pages connected to this study.